Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion of human neutrophils to endothelial cells

British Journal of Pharmacology

Volumn 148, Issue 5, 2006, Pages 648-656

  Dianzani, Chiara ^a,d   Cavalli, Roberta ^a   Zara, Gian Paolo ^a   Gallicchio, Margherita ^a   Lombardi, Grazia ^b   Gasco, Maria Rosa ^c   Panzanelli, Patrizia ^a   Fantozzi, Roberto ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c NANOVECTOR S R L   (Italy)

^d Department of Anatomy Pharmacology and Forensic Medicine ^*  (Italy)

Author keywords

Adhesion; Chol but SLN; GPR41 and GPR43 receptors; HUVEC; Neutrophil; PMNs; Sodium butyrate

Indexed keywords

BUTYRIC ACID; BUTYRIC ACID DERIVATIVE; CHOLESTEROL BUTYRATE; CHOLESTEROL ESTER; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTERLEUKIN 1BETA; LIPID; MYELOPEROXIDASE; NANOPARTICLE; OXYGEN; PRODRUG; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELL ADHESION; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG DELIVERY SYSTEM; ENDOTHELIUM CELL; ENTERITIS; ENZYME RELEASE; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; INFLAMMATION; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ULCERATIVE COLITIS; VASCULAR ENDOTHELIUM;

BUTYRATES; CELL ADHESION; CELL SURVIVAL; CELLS, CULTURED; CHOLESTEROL ESTERS; ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-1BETA; LIPIDS; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NANOPARTICLES; NEUTROPHILS; PEROXIDASE; SUPEROXIDES;

EID: 33745611176     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706761     Document Type: Article

References (45)

1. AVANZI, G.C., GALLICCHIO, M., BOTTAREL, F., GAMMAITONI, L., CAVALLONI, G., BUOFIGLIO, D., BRAGARDO, M., BELLOMO, G., ALBANO, E., FANTOZZI, R., GARBARINO, G., VARNUM, B., AGLIETTA, M., SAGLIO, G., DIANZANI, U. & DIANZANI, C. (1998). GAS6 inhibits granulocyte adhesion to endothelial cells. Blood, 91, 2334-2340.
2. BENDAS, G. (2005). Inhibitors of membrane receptors involved with leukocyte extravasation. Mini Rev. Med. Chem., 5, 575-584.
3. BROWN, A.J., GOLDSWORTHY, S.M., BARNES, A.A., EILERT, M.M., TCHEANG, L., DANIELS, D., MUIR, A.I., WIGGLESWORTH, M.J., KINGHORN, I., FRASER, N.J., PIKE, N.B., STRUM, J.C., STEPLEWSKI, K.M., MURDOCK, P.R., HOLDER, J.C., MARSHALL, F.H., SZEKERES, P.G., WILSON, S., IGNAR, D.M., FOORD, S.M., WISE, A. & DOWEL, S.J. (2003). The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short-chain carboxylic acids. J. Biol. Chem., 278, 11312-11319.
4. BRUNKHORST, B.A., KRAUS, E., COPPI, M., BUDNICK, M. & NIEDERMAN, R. (1992). Propionate induces polymorpho-nuclear leukocyte activation and inhibits formylmethionylleucyl-phenylalanine-stimulated activation. Infect. Immun., 60, 2957-2968.
5. CAVALLI, R., BARGONI, A., PODIO, V., MUNTONI, E., ZARA, G.P. & GASCO, M.R. (2002). Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin. J. Pharmc. Sci., 92, 1085-1094.
6. CONLEY, B.A., EGORIN, M.J., TAIT, N., ROSEN, D.M., SAUSVILLE, E.A., DOVER, G., FRAM, J.R. & VAN ECHO, D.A. (1998). Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors. Clin. Cancer Res., 4, 629-634.
7. D'ARGENIO, G., COSENZA, V., DELLE CAVE, M., IOVINO, P., DELLE VALLE, N., LOMBARDI, G. & MAZZACCA, G. (1996). Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model. Gastroenterologe, 110, 1727-1734.
8. DIANZANI, C., COLLINO, M., LOMBARDI, G., GARBARINO, G. & FANTOZZI, R. (2003). Substance P increases neutrophil adhesion to human umbelical vein endothelial cells. Br. J. Pharmacol., 139, 1103-1110.
9. DUNCAN, I.W. (1979). Determination of free, total, and esterified cholesterol by high performance liquid chromatography. J. Chromatogr., 162, 281-292.
10. DYER, J.P., FEATHERSTONE, J.M., SOLOMON, L.Z., CROOK, T.J., COOPER, A.J. & MALONE, P.S. (2005). The effect of short-chain fatty acids butyrate, propionate, and acetate on urothelial cell kinetics in vitro: potential therapy in augmentation cystoplasty. Pediatr. Surg. Int., 21, 521-526.
11. EDELMAN, M.J., BAUER, K., KHANWANI, S., TAIT, N., TREPEL, J., KARP, J., NEMIEBOKA, N., CHUNG, E.J. & VAN ECHO, D. (2003). Clinical and pharmacologic study of tributyrin: an oral butyrate prodrug. Cancer Chemother. Pharmacol., 51, 439-444.
12. EFTIMIADI, C., BUZZI, E., TONETTI, M., BUFFA, P., BUFFA, D., VAN STEENBERGEN, M.T.J., DE GRAAF, J. & BOTTA, G.A. (1987). Short-chain fatty acids produced by anaerobic bacteria alter the physiological responses of human neutrophils to chemotactic peptide. J. Infection, 14, 43-53.
13. GASCO, M.R. (2001). Solid lipid nanoparticles for drug delivery. Pharm. Technol. Eur., 13, 32-41.
14. GASCO, M.R. (2004). Solid lipid nanospheres suitable to a fast internalization into cells. EP 1133286, (24/11/2004) - U.S. 6.685.960 (3/02/2004).
15. GLOTZER, D.J., GLICK, M.E. & GOLDMAN, H. (1981). Proctitis and colitis following diversion of the fecal stream. Gastroenterology, 80, 438-441.
16. HALLERT, C., BJORCK, I., NYMAN, M., POUSETTE, A., GRANNO, C. & SVENSSON, H. (2003). Increasing fecal butyrate in ulcerative colitis patients by diet: controlled pilot study. Inflamm. Bowel Dis., 9, 116-121.
17. HENSON, P.M., ZANOLARI, B., SCHWARTZMAN, N.A. & HONG, S.R. (1978). Intracellular control of human neutrophil secretion I. C5a-induced stimulus-specific desensitization and the effects of cytochalasin B. J. Immunol., 121, 851-855.
18. KLAMPFER, L., HUANG, J., SASAZUKI, T., SHIRASAWA, S. & AUGENLICHT, L. (2003). Inhibition of interferon gamma signaling by the short chain fatty acid butyrate. Mol. Cancer Res., 1, 855-862.
19. KOPPEL, D.E. (1972). Analysis of macromolecular polydispersity in intensity correlation spectroscopy: the method of cumulant. J. Chem. Phys., 57, 4814-4818.
20. LE POUL, E., LOISON, C., STRUYF, S., SPRINGAEL, J.-Y., LANNOY, V., DECOBECQ, M.-E., BREZILLON, S., DUPRIEZ, V., VASSART, G., VAN DAMME, J., PARMENTIER, M. & DETHEUX, M. (2003). Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J. Biol. Chem., 278, 25481-25489.
21. LIU, Q., SHIMOYAMA, T., SUZUKI, K., UMEDA, T., NAKAJI, S. & SUGAWARA, K. (2001). Effect of sodium butyrate on reactive oxygen species generation by human neutrophils. Scand. J. Gastroenterol., 36, 744-750.
22. MANJUNATH, K., REDDY, J.S. & VENKATESWARLU, V. (2005). Solid lipid nanoparticles as drug delivery systems. Methods Find. Exp. Clin. Pharmacol., 27, 127-144.
23. MCLEISH, K.R., KNALL, C., WARD, R.A., GERWINS, P., COXON, P.Y., KLEIN, J.B. & JOHNSON, G.L. (1998). Activation of mitogen-activated protein kinase cascades during priming of human neutrophils by TNF-alpha and GM-CSF. J. Leukoc. Biol., 64, 537-545.
24. MENZEL, T., LUHRS, H., ZIRLIK, S., SCHAUBER, J., KUDLICH, T., GERKE, T., GOSTNER, A., NEUMANN, M., MELCHER, R. & SCHEPPACH, W. (2004). Butyrate inhibits leukocyte adhesion to endothelial cells via modulation of VCAM-1. Inflamm. Bowel Dis., 10, 122-128.
25. MOSMANN, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65, 55-63.
26. MÜLLER, R.H. (1991). Colloidal Carriers for Controlled Drug Delivery ami Targeting. Boca raton, Florida, U.S.A.: CRC Press.
27. NICK, J.A., AVDI, N.J., YOUNG, S.K., KNALL, C., GERWINS, P., JOHNSON, G.L. & WORTHEN, G.S. (1997). Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP. J. Clin. Invest., 99, 975-986.
28. 2R, expressed on leukocytes and activated by short-chain fatty acids. Biochem. Biophys. Res. Commun., 303, 1047-1052.
29. OGAWA, H., RAFIEE, P., FISHER, P.J., JOHNSON, N.A., OTTERSON, M.F. & BINION, D.G. (2003). Butyrate modulates gene and protein expression in human intestinal endothelial cells. Biochem. Biophy. Res. Commun., 309, 512-519.
30. PARK, J.S., WOO, M.S., KIM, S.Y., KIM, W.K. & KIM, H.S. (2005). Repression of interferon-gamma-induced inducible nitric oxide synthase (iNOS) gene expression in microglia by sodium butyrate is mediated through specific inhibition of ERK signaling pathways. J. Neuroimmunol., 168, 56-64.
31. PATNAIK, A., ROWINSKY, E.K., VILLALONA, M.A., HAMMOND, L.A., BRITTEN, C.D., SIU, L.L., GOETZ, A., FELTON, S.A., BURTON, S., VALONE, F.H. & ECKHARDT, S.G. (2002). A phase I study of pivaloyloxymethyl butyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies. Clin. Cancer Res., 8, 2142-2148.
32. PELLIZZARO, C., CORADINI, D., MOREL, S., UGAZIO, E., GASCO, M.R. & DAIDONE, M.G. (1999). Cholesteryl butyrate in solid lipid nanospheres as an alternative approach for butyric acid delivery. Anticancer Res., 19, 3921-3926.
33. REID, T., VALONE, F., LIPERA, W., IRWIN, D., PAROLY, W., NATALE, R., SREEDHARAN, S., KEER, H., LUM, B., SCAPPATICCI, F. & BHATNAGAR, A. (2004). Phase II trial of the histone deacetylase inhibitor pivaloyloxymethyl butyrate (Pivanex, AN-9) in advanced non-small cell lung cancer. Lung Cancer, 45, 381-386.
34. RODRIGUEZ-CABEZAS, M.E., GALVEZ, J., CAMUESCO, D., LORENTE, M.D., CONCHA, A., MARTINEZ-AUGUSTIN, O., REDONDO, L. & ZARZUELO, A. (2003). Intestinal anti-inflammatory activity of dietary fiber (Plantago ovata seeds) in HLA-B27 transgenic rats. Clin. Nutr., 22, 463-471.
35. SALOMONE, B., PONTI, R., GASCO, M.R., UGAZIO, E., QUAGLINO, P., OSELLA-ABATE, S. & BERNENGO, M.G. (2001). In vitro effects of cholesteryl butyrate solid lipd nanospheres as a butyric acid prodrug on melanoma cells: evaluation of antiproliferative activity and apoptosis induction. Clinic. Experim. Metast., 18, 663-673.
36. SCHEPPACH, W. & WEILER, F. (2004). The butyrate story: old wine in new bottles? Curr. Opin. Clin. Nutr. Metah. Care, 7, 563-567.
37. SEGAIN, J.P., RAINGEARD DE LA BLETIERE, D., BOURREILLE, A., LERAY, V., GERVOIS, N., ROSALES, C., FERRIER, L., BONNET, C., BLOTTIERE, H.M. & GALMICHE, J.P. (2000). Butyrate inhibits inflammatory responses through NFkB inhibition: implications for Crohn's disease. Gut, 47, 397-403.
38. SENGA, T., IWAMOTO, S., YOSHIDA, T., YOKOTA, T., ADACHI, K., AZUMA, E., HAMAGUCHI, M. & IWAMOTO, T. (2003). LSSIG is a novel murine leukocyte-specific GPCR that is induced by the activation of STAT3. Blood, 101, 1185-1187.
39. SERPE, L., LAURORA, S., PIZZIMENTI, S., UGAZIO, E., PONTI, R., CANAPARO, R., BRIATORE, F., BARRERA, G., GASCO, M.R., BERNENGO, M.G., EANDI, M. & ZARA, G.P. (2004). Cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug: effects on cell proliferation, cell cycle distribution and c-myc expression in human leukemic cells. Anti Cancer Drugs, 15, 525-536.
40. VENKATRAMAN, A., RAMAKRISHNA, B.S., SHAJI, R.V., KUMAR, N.S., PULIMOOD, A. & PATRA, S. (2003). Amelioration of dextran sulfate colitis by butyrate: role of the shock protein 70 and NF-kappaB. Am. J. Physiol. Gastrointest. Liver Physiol., 285, G177-G184.
41. VERNIA, P., ANNESE, V., BRESCI, G., D'ALBASIO, G., D'INCA, R., GIACCARI, S., INGROSSO, M., MANSI, C., RIEGLER, G., VALPIANI, D. & CAPRILLI, R. (2003). Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial. Eur. J. Clin. Invest., 33, 244-248.
42. WANG, Q., YERUKHIMOVICH, M., GAARDE, W.A., POPOFF, I.J. & DOERSCHUK, C.M. (2005). MKK3 and -6-dependent activation of p38α MAP kinase is required for cytoskeletal changes in pulmonary microvascular endothelial cells induced by ICAM-1 ligation. Am. J. Physiol. Lung Cell Mol. Physiol., 288, L359-L369.
43. WESTESEN, K., BUNJES, H. & KOCH, H.J. (1997). Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J. Control Rel., 48, 223-236.
44. XIONG, Y., MIYAMOTO, N., SHIBATA, K., VALASEK, M.A., MOTOIKE, T., KEDZIERSKI, R.M. & YANAGISAWA, M. (2004). Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. PNAS, 101, 1045-1050.
45. ZAPOLSKA-DOWNAR, D., SIENNICKA, A., KACZMARCZYK, M., KOLODZIEJ, B. & NARUSZEWICZ, M. (2004). Butyrate inhibits cytokine-induced VCAM-1 and ICAM-1 expression in cultured endothelial cells: the role of NF-kB and PPARα. J. Nutr. Biochem., 15, 220-228.